Results 121 to 130 of about 4,991,114 (167)

Renal involvement in Fabry disease from Tunisian families: Six case reports. [PDF]

World J Nephrol
Tlili S, Ghabi H, Mami I, Ben Hmida F, Rais L, Zouaghi MK.   +5 more
europepmc   +1 more source

Newborn screening for Fabry disease in Japan: an additional 3-year report. [PDF]

Mol Genet Metab Rep
Sawada T, Kido J, Sugawara K, Yoshida S, Inoue T, Hirose S, Nakamura K.   +6 more
europepmc   +1 more source

Population Pharmacokinetic Modeling for the Iminosugar Lucerastat Supports Dose Adaptation in Patients With Fabry Disease and Moderate to Severe Renal Function Impairment. [PDF]

J Clin Pharmacol
Brussee JM, Dingemanse J, Lott D, Berger B, Frey A, Krause A.   +5 more
europepmc   +1 more source

Neurological management and outcome measures in Fabry disease: consensus statements from the Italian Fabry disease neurological working group. [PDF]

Orphanet J Rare Dis
Mancuso M, Burlina A, Ulivi L, Cocozza S, Bersano A, Cosottini M, Donadio V, Giordano A, Liguori R, Manara R, Pichiecchio A, Romani I, Siniscalchi A, Tenuta M, Cianci V, Tuttolomondo A.   +15 more
europepmc   +1 more source

Increased Risk of Injury in Patients with Fabry Disease: A Nationwide Population-Based Cohort Study in Taiwan. [PDF]

Int J Med Sci
Cheng CG, Chen YH, Chien WC, Chiu HW, Hung FH, Peng HP, Chung CH, Cheng CA.   +7 more
europepmc   +1 more source

Pathogenic mechanisms in Fabry disease. [PDF]

Front Med (Lausanne)
Wang S, Sun C.
europepmc   +1 more source

Case Report: Fabry disease mimicking coronary artery disease and hypertrophic cardiomyopathy-a 15-year diagnostic delay. [PDF]

Front Cardiovasc Med
Liang T, Xu H, Huang C.
europepmc   +1 more source

Progressive Conduction System Disease Preceding Hypertrophy in IVS4 + 919G > A Fabry Variant: a Population-based Electrocardiographic Study. [PDF]

Europace
Chung WH, Tung CC, Liu TY, Chang WJ, Chang KC, Lin WD, Liang HY, Tsai FJ.   +7 more
europepmc   +1 more source

Prevalence and sociodemographic, clinical, and genetic characteristics of Fabry disease in north-central Chile, 2013-2023. [PDF]

Mol Genet Metab Rep
Royo Martínez S, Castillo-Montes M, Molt F, Cortes Rivera B, Ramírez-Santana M.   +4 more
europepmc   +1 more source

Multimodal phenotypic clustering predicts cardiac outcomes in Fabry disease. [PDF]

Orphanet J Rare Dis
Shemesh E, Feigin P, Tan CY, Rusk R, Gopalan D, Deegan P.   +5 more
europepmc   +1 more source